Abbott Laboratories First Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Net income: US$1.23b (down 6.6% from 1Q 2023). Profit margin: 12% (down from 14% in 1Q 2023). The decrease in margin was driven by higher expenses. EPS: US$0.70 (down from US$0.75 in 1Q 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Abbott Laboratories EPS Beats Expectations Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 6.2%. Looking ahead, revenue is forecast to grow 6.3% p.a. on average during the next 3 years, compared to a 8.0% growth forecast for the Medical Equipment industry in the US. Performance of the American Medical Equipment industry. The company's shares are down 4.7% from a week ago. Balance Sheet Analysis While earnings are important, another area to consider is the balance sheet. See our latest analysis on Abbott Laboratories' balance sheet health. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively,
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Global Functional Dyspepsia Drug Market to reach a valuation of US$ 16.4 billion by 2034, Future Market Insights, Inc. Projection [Yahoo! Finance]Yahoo! Finance
- Legionella Testing Global Market Report 2024: Increasing Legionella Testing Demand From Hospitality Sector and Rising Incidence of Pneumonia and Legionella-related Illnesses [Yahoo! Finance]Yahoo! Finance
- Global Drug-Eluting Stents Strategic Research Report 2024-2030: Biodegradable Polymers Represent Promising Developments, Offering the Potential for Enhanced Biocompatibility [Yahoo! Finance]Yahoo! Finance
- Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee [Yahoo! Finance]Yahoo! Finance
- Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the KneePR Newswire
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 4/30/24 - Form 4
- 4/30/24 - Form 4
- 4/30/24 - Form 4
- ABT's page on the SEC website